Association of Gestational Diabetes Mellitus with Multi Drug Resistant Vaginal Infections among Pregnant Women
DOI:
https://doi.org/10.70749/ijbr.v3i2.614Keywords:
Bacterial Vaginosis, MDR-TB, Gestational Diabetes Mellitus, Gram-positive Bacteria, Gram-negative Bacteria, CandidaAbstract
Background: Vaginal infections caused by various pathogenic microorganisms, along with the emergence of antibiotic resistance, pose significant medical challenges. Gestational diabetes mellitus (GDM) is a critical factor that can delay recovery from infections and lead to complications. Methodology: This study was conducted as a cross-sectional analysis involving pregnant women. A total of 120 vaginal swabs were collected from participants and analyzed to identify the microorganisms present and assess their antibiotic susceptibility. The subjects were categorized into two groups based on their diabetic status: those with GDM and those without. Various biochemical tests, culturing methods, and sensitivity patterns were performed on high vaginal swab isolates. Results: The analysis revealed that 56% of the women studied were aged between 23 and 37 years, with 67% in their third trimester. Among the microorganisms identified, Candida species accounted for 51%, while gram-positive bacteria comprised 24.3% and gram-negative bacteria 25.19%. Within the gram-positive category, Methicillin-resistant Staphylococcus aureus (MRSA) was the most prevalent at 30.25%, followed by Enterococcus faecalis at 15% and Streptococcus species at 3.11%. For gram-negative bacteria, Klebsiella pneumoniae was found in 44.4% of cases, E. coli in 31.3%, Pseudomonas aeruginosa in 14.1%, Pseudomonas stutzeri in 6.05%, and Acinetobacter baumannii in 3.02%. Susceptibility testing indicated that Staphylococcus aureus was primarily sensitive to Linezolid but resistant to azithromycin, while vancomycin and cotrimoxazole were most effective against MRSA, with cloxacillin showing significant resistance. Vancomycin was also the most effective treatment for E. faecalis, whereas azithromycin exhibited high resistance levels. Among gram-negative bacteria, Gentamicin was most effective against E. coli, while Rofloxacin showed the highest resistance; Imipenem was most effective against P. aeruginosa, with Amikacin showing significant resistance. A significant association was found between multidrug-resistant (MDR) vaginal infections and GDM. Conclusion: The study concluded that there is no significant association between MDR vaginal infections and gestational diabetes mellitus among pregnant women.
Downloads
References
Ottinger, S., Robertson, C. M., Branthoover, H., & Patras, K. A. (2024). The human vaginal microbiota: From clinical medicine to models to mechanisms. Current Opinion in Microbiology, 77, 102422. https://doi.org/10.1016/j.mib.2023.102422
Chee, W. J., Chew, S. Y., & Than, L. T. (2020). Vaginal microbiota and the potential of lactobacillus derivatives in maintaining vaginal health. Microbial Cell Factories, 19(1). https://doi.org/10.1186/s12934-020-01464-4
Barrientos-Durán, A., Fuentes-López, A., De Salazar, A., Plaza-Díaz, J., & García, F. (2020). Reviewing the composition of vaginal microbiota: Inclusion of nutrition and probiotic factors in the maintenance of Eubiosis. Nutrients, 12(2), 419. https://doi.org/10.3390/nu12020419
Moosa, Y., Kwon, D., De Oliveira, T., & Wong, E. B. (2020). Determinants of vaginal microbiota composition. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.00467
Alhabardi, S. M., Edris, S., Bahieldin, A., & Al-Hindi, R. R. (2021). The composition and stability of the vaginal microbiome of healthy women. Journal of the Pakistan Medical Association, 1-20. https://doi.org/10.47391/jpma.1465
Chen, X., Lu, Y., Chen, T., & Li, R. (2021). The female vaginal microbiome in health and bacterial vaginosis. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.631972
Kovachev, S. (2017). Defence factors of vaginal lactobacilli. Critical Reviews in Microbiology, 44(1), 31-39. https://doi.org/10.1080/1040841x.2017.1306688
Zare, H., Izadi Amoli, R., Rezapour, M., Zaboli, F., & Kaboosi, H. (2024). Characterization of vaginal lactobacilli with potential probiotic properties isolated from healthy women in Northern Iran. Indian Journal of Microbiology, 64(2), 529-539. https://doi.org/10.1007/s12088-023-01186-2
Pendharkar, S., Skafte-Holm, A., Simsek, G., & Haahr, T. (2023). Lactobacilli and their probiotic effects in the vagina of reproductive age women. Microorganisms, 11(3), 636. https://doi.org/10.3390/microorganisms11030636
Kalinina, N. A., Sulima, A. N., Rumyantseva, Z. S., Rybalka, A. N., Baskakov, P. N., Voronaya, V. V., & Lyashenko, A. S. (2022). Dominant Lactobacillus spp. in different conditions of vaginal microbiocenosis. Journal of obstetrics and women's diseases, 71(3), 65-76. https://doi.org/10.17816/jowd90673
Zheng, N., Guo, R., Wang, J., Zhou, W., & Ling, Z. (2021). Contribution of lactobacillus iners to vaginal health and diseases: A systematic review. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.792787
Lykke, M. R., Becher, N., Haahr, T., Boedtkjer, E., Jensen, J. S., & Uldbjerg, N. (2021). Vaginal, cervical and uterine pH in women with normal and abnormal vaginal microbiota. Pathogens, 10(2), 90. https://doi.org/10.3390/pathogens10020090
Lin, Y., Chen, W., Cheng, C., & Shen, C. (2021). Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics, 11(11), 1996. https://doi.org/10.3390/diagnostics11111996
Lin, Y., Chen, W., Cheng, C., & Shen, C. (2021). Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics, 11(11), 1996. https://doi.org/10.3390/diagnostics11111996
Test PV, Insert P. Screen Vaginal PH Test. https://www.screenitalia.it/Istruzioni%20Screen%20Check%20Test%20pH%20Vaginale%20(ING).pdf
Lev-Sagie, A., De Seta, F., Verstraelen, H., Ventolini, G., Lonnee-Hoffmann, R., & Vieira-Baptista, P. (2022). The vaginal microbiome: II. Vaginal Dysbiotic conditions. Journal of Lower Genital Tract Disease, 26(1), 79-84. https://doi.org/10.1097/lgt.0000000000000644
Shen, L., Zhang, W., Yuan, Y., Zhu, W., & Shang, A. (2022). Vaginal microecological characteristics of women in different physiological and pathological period. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.959793
Çalık, K. Y., Erkaya, R., İnce, G., & Yıldız, N. K. (2020). Genital hygiene behaviors of women and their effect on vaginal infections. Clinical and Experimental Health Sciences, 10(3), 210-216. https://doi.org/10.33808/clinexphealthsci.565845
Lin, Y., Chen, W., Cheng, C., & Shen, C. (2021). Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics, 11(11), 1996. https://doi.org/10.3390/diagnostics11111996
Kalia, N., Singh, J., & Kaur, M. (2020). Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: A critical review. Annals of Clinical Microbiology and Antimicrobials, 19(1). https://doi.org/10.1186/s12941-020-0347-4
Sobel, J. D., & Vempati, Y. S. (2024). Bacterial vaginosis and Vulvovaginal candidiasis Pathophysiologic interrelationship. Microorganisms, 12(1), 108. https://doi.org/10.3390/microorganisms12010108
García-Carnero, L. C., Gómez-Gaviria, M., Tamez-Castrellón, A. K., & Mora-Montes, H. M. (2024). Host immune responses to fungal infection. Molecular Medical Microbiology, 2823-2846. https://doi.org/10.1016/b978-0-12-818619-0.00136-2
Balakrishnan, S. N., Yamang, H., Lorenz, M. C., Chew, S. Y., & Than, L. T. (2022). Role of vaginal mucosa, host immunity and microbiota in Vulvovaginal candidiasis. Pathogens, 11(6), 618. https://doi.org/10.3390/pathogens11060618
Strzelec, M., Detka, J., Mieszczak, P., Sobocińska, M. K., & Majka, M. (2023). Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1127704
Han, Y., Liu, Z., & Chen, T. (2021). Role of vaginal microbiota Dysbiosis in Gynecological diseases and the potential interventions. Frontiers in Microbiology, 12. https://doi.org/10.3389/fmicb.2021.643422
Sadeghpour Heravi, F. (2024). Host-vaginal microbiota interaction: Shaping the vaginal microenvironment and bacterial vaginosis. Current Clinical Microbiology Reports, 11(3), 177-191. https://doi.org/10.1007/s40588-024-00227-8
Pendharkar, S., Skafte-Holm, A., Simsek, G., & Haahr, T. (2023). Lactobacilli and their probiotic effects in the vagina of reproductive age women. Microorganisms, 11(3), 636. https://doi.org/10.3390/microorganisms11030636
CHITULEA, P. (2022). The role of intravaginal prebiotics in controlling the evolution of uncomplicated bacterial and fungal vaginal infections. FARMACIA, 70(3), 545-549. https://doi.org/10.31925/farmacia.2022.3.22
Shen, L., Zhang, W., Yuan, Y., Zhu, W., & Shang, A. (2022). Vaginal microecological characteristics of women in different physiological and pathological period. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.959793
Auriemma, R. S., Scairati, R., Del Vecchio, G., Liccardi, A., Verde, N., Pirchio, R., Pivonello, R., Ercolini, D., & Colao, A. (2021). The vaginal microbiome: A long urogenital colonization throughout woman life. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.686167
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022). Towards a deeper understanding of the vaginal microbiota. Nature Microbiology, 7(3), 367-378. https://doi.org/10.1038/s41564-022-01083-2
Holdcroft, A. M., Ireland, D. J., & Payne, M. S. (2023). The vaginal microbiome in health and disease—What role do common intimate hygiene practices play? Microorganisms, 11(2), 298. https://doi.org/10.3390/microorganisms11020298
Cocomazzi, G., De Stefani, S., Del Pup, L., Palini, S., Buccheri, M., Primiterra, M., Sciannamè, N., Faioli, R., Maglione, A., Baldini, G. M., Baldini, D., & Pazienza, V. (2023). The impact of the female genital microbiota on the outcome of assisted reproduction treatments. Microorganisms, 11(6), 1443. https://doi.org/10.3390/microorganisms11061443
Holdcroft, A. M., Ireland, D. J., & Payne, M. S. (2023). The vaginal microbiome in health and disease—What role do common intimate hygiene practices play? Microorganisms, 11(2), 298. https://doi.org/10.3390/microorganisms11020298
Salinas, A. M., Osorio, V. G., Pacha-Herrera, D., Vivanco, J. S., Trueba, A. F., & Machado, A. (2020). Vaginal microbiota evaluation and prevalence of key pathogens in ecuadorian women: An epidemiologic analysis. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-74655-z
Superti, F., & De Seta, F. (2020). Warding off recurrent yeast and bacterial vaginal infections: Lactoferrin and lactobacilli. Microorganisms, 8(1), 130. https://doi.org/10.3390/microorganisms8010130
Rizo, M. E., Puentes, A. A., Puentes, R. A., Tejeda, M. M., & Rodríguez, P. R. (2023). Clinical epidemiological characterization of vaginal infection in pregnant. “Orlando Matos Mosquera” polyclinic, 2019 -2021. Mathews Journal of Case Reports, 8(6). https://doi.org/10.30654/mjcr.10111
Salinas, A. M., Osorio, V. G., Pacha-Herrera, D., Vivanco, J. S., Trueba, A. F., & Machado, A. (2020). Vaginal microbiota evaluation and prevalence of key pathogens in ecuadorian women: An epidemiologic analysis. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-74655-z
Dos Santos, A. M., Carvalho, S. G., Araujo, V. H., Carvalho, G. C., Gremião, M. P., & Chorilli, M. (2020). Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections. International Journal of Pharmaceutics, 590, 119867. https://doi.org/10.1016/j.ijpharm.2020.119867
Superti, F., & De Seta, F. (2020). Warding off recurrent yeast and bacterial vaginal infections: Lactoferrin and lactobacilli. Microorganisms, 8(1), 130. https://doi.org/10.3390/microorganisms8010130
Gaziano, R., Sabbatini, S., Roselletti, E., Perito, S., & Monari, C. (2020). Saccharomyces cerevisiae-based probiotics as novel antimicrobial agents to prevent and treat vaginal infections. Frontiers in Microbiology, 11. https://doi.org/10.3389/fmicb.2020.00718
Chen, X., Lu, Y., Chen, T., & Li, R. (2021). The female vaginal microbiome in health and bacterial vaginosis. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.631972
Coudray, M. S., & Madhivanan, P. (2020). Bacterial vaginosis—A brief synopsis of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 143-148. https://doi.org/10.1016/j.ejogrb.2019.12.035
Chacra, L. A., Fenollar, F., & Diop, K. (2022). Bacterial vaginosis: What do we currently know? Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.672429
Morrill, S., Gilbert, N. M., & Lewis, A. L. (2020). Gardnerella vaginalis as a cause of bacterial vaginosis: Appraisal of the evidence from in vivo models. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.00168
Ellington, K., & Saccomano, S. J. (2020). Recurrent bacterial vaginosis. The Nurse Practitioner, 45(10), 27-32. https://doi.org/10.1097/01.npr.0000696904.36628.0a
Ding, C., Yu, Y., & Zhou, Q. (2021). Bacterial vaginosis: Effects on reproduction and its therapeutics. Journal of Gynecology Obstetrics and Human Reproduction, 50(9), 102174. https://doi.org/10.1016/j.jogoh.2021.102174
Muzny, C. A., & Schwebke, J. R. (2020). Asymptomatic bacterial vaginosis: To treat or not to treat? Current Infectious Disease Reports, 22(12). https://doi.org/10.1007/s11908-020-00740-z
Waikhom, S. D., Afeke, I., Kwawu, G. S., Mbroh, H. K., Osei, G. Y., Louis, B., Deku, J. G., Kasu, E. S., Mensah, P., Agede, C. Y., Dodoo, C., Asiamah, E. A., Tampuori, J., Korbuvi, J., & Opintan, J. A. (2020). Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: Species identification and antifungal susceptibility of candida isolates. BMC Pregnancy and Childbirth, 20(1). https://doi.org/10.1186/s12884-020-02963-3
Disha, T., & Haque, F. (2022). Prevalence and risk factors of Vulvovaginal Candidosis during pregnancy: A review. Infectious Diseases in Obstetrics and Gynecology, 2022, 1-14. https://doi.org/10.1155/2022/6195712
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
